J G Kang
Overview
Explore the profile of J G Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Ryoo J, Kang J, Jung J
J Endocrinol Invest
. 2020 May;
44(1):111-117.
PMID: 32383145
Purpose: It has been demonstrated that variation in thyroid hormone levels even within normal range was associated with increased cardiovascular risk. However, available data are still insufficient on association between...
2.
Kim S, Kang J, Kim C, Ihm S, Choi M, Yoo H, et al.
J Endocrinol Invest
. 2017 Nov;
41(6):677-689.
PMID: 29147952
Purpose: The influence of the dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with the histone deacetylase inhibitor PXD101 on survival of thyroid carcinoma cells was investigated. Methods: SW1736, TPC-1,...
3.
Hwang Y, Kang J, Ahn K, Cha B, Ihm S, Lee S, et al.
Int J Clin Pract
. 2014 Oct;
68(11):1338-44.
PMID: 25284679
Aims: In this study, we compared the glucose-lowering effectiveness of insulin analogues and their combination according to baseline glycemic status in patients with type 2 diabetes (T2D) from the A1...
4.
Kim S, Kang J, Kim C, Ihm S, Choi M, Yoo H, et al.
J Endocrinol Invest
. 2013 Oct;
36(11):1099-104.
PMID: 24084189
Aim of the present study was to evaluate the effect of apigenin in combination with BRAFV600E inhibitor PLX4032 on cell survival, and to investigate the influence of Akt inhibition on...
5.
Kim S, Kang J, Kim C, Ihm S, Choi M, Yoo H, et al.
Horm Metab Res
. 2013 Feb;
45(6):408-14.
PMID: 23386415
SU6656 is a small-molecule indolinone that selectively inhibits Src family kinase and induces death of cancer cells. The aim of the present study was to investigate the influence of SU6656...
6.
Kim S, Kang J, Kim C, Ihm S, Choi M, Yoo H, et al.
Horm Metab Res
. 2012 Aug;
45(1):9-14.
PMID: 22918703
SU5416, vascular endothelial cell growth factor receptor inhibitor, suppresses hypoxia-induced angiogenesis, growth, proliferation, and metastasis in cancer cells. CCAAT/enhancer-binding protein-homologous protein (CHOP) has pivotal roles in regulation of growth and...
7.
Lee S, Kim S, Kang J, Kim C, Ihm S, Choi M, et al.
Horm Metab Res
. 2011 May;
43(7):445-51.
PMID: 21590646
Alpha-lipoic acid (ALA) has been shown to modulate cell death via PI3K/Akt signal pathway in various cells. In the present study, the effects of ALA on cell death and PI3K/Akt...
8.
Lee S, Kim S, Kang J, Kim C, Ihm S, Choi M, et al.
Horm Metab Res
. 2011 Jan;
43(5):331-6.
PMID: 21225541
In thyroid cells, the effects of all- TRANS retinoic acid (ATRA) on sodium/iodide symporter (NIS) and CCAAT/enhancer-binding protein-homologous protein (CHOP) under condition of endoplasmic reticulum (ER) stress have not been...
9.
Kang J, Park C, Kang J, Park Y, Park S
Diabetes Obes Metab
. 2010 Oct;
12(10):876-82.
PMID: 20920040
Aim: To evaluate the efficacy and safety of a newly developed formulation of phentermine diffuse-controlled release (DCR) in patients with obesity. Methods: This was a randomized, double-blind, placebo-controlled trial of...
10.
Kang J, Ko J, Kim G, Gwak M, Kim Y, Lee S
Transplant Proc
. 2010 May;
42(3):854-7.
PMID: 20430189
Purpose: Orthotopic liver transplantation (OLT) patients are known to show decreased intraoperative anesthetic requirements compared with patients undergoing other liver surgeries. The aim of this study was to determine the...